Skip to content

Application of Early Goal-directed Sedation in Patients With Severe Brain Injury

Application of Early Goal-directed Sedation in Patients With Severe Brain Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04525482
Enrollment
300
Registered
2020-08-25
Start date
2017-01-01
Completion date
2019-12-31
Last updated
2020-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Traumatic

Keywords

Brain Injuries, Early Goal-directed Sedation

Brief summary

EGDS management strategy was implemented in ICU patients with severe brain injury, the depth of sedation and GCS score were monitored, and the protective effects of EGDS strategy and standard sedation strategy on the brain of patients with severe brain injury were discussed.

Interventions

OTHEREarly goal-directed sedation programs

A. Provide sedation at the beginning of the titration of dextrometomidine; b. Optimize sedation when dextrometomidine is used alone and at a maximum dose not sufficient to provide comfort and safety to the patient and to achieve a level of sedation at any time specified by the treating physician. C. Provides immediate recovery and sedation, and can control sudden agitation at any time

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of severe craniocerebral injury * The GCS score is 6 to 12 points * Within 12 hours of intubation * The mechanical ventilation time is greater than 24 hours * Obtain written consent

Exclusion criteria

* Pregnant women * Acute liver failure * Dementia or mental illness

Design outcomes

Primary

MeasureTime frame
Richmond Agitation-Sedation Scalethrough study completion, an average of 2 year
Mechanical ventilation timethrough study completion, an average of 2 year
length of stay in ICUthrough study completion, an average of 2 year

Secondary

MeasureTime frame
complicationthrough study completion, an average of 2 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026